BIOMAT Database Logo BIOMAT Database Logo

Alcoholic liver disease with resistant ascites and reinfusion therapy. 1984

J J Alberti-Flor, and G D Dunn

UI MeSH Term Description Entries
D008108 Liver Diseases, Alcoholic Liver diseases associated with ALCOHOLISM. It usually refers to the coexistence of two or more subentities, i.e., ALCOHOLIC FATTY LIVER; ALCOHOLIC HEPATITIS; and ALCOHOLIC CIRRHOSIS. Alcoholic Liver Diseases,Alcoholic Liver Disease,Liver Disease, Alcoholic
D010951 Plasma Exchange Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions. Exchange, Plasma,Exchanges, Plasma,Plasma Exchanges
D004322 Drainage The removal of fluids or discharges from the body, such as from a wound, sore, or cavity.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001201 Ascites Accumulation or retention of free fluid within the peritoneal cavity.
D014511 Uremia A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms. Uremias

Related Publications

J J Alberti-Flor, and G D Dunn
Cell-Free and Concentrated Ascites Reinfusion Therapy for Decompensated Liver Cirrhosis.
August 2016, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy,
J J Alberti-Flor, and G D Dunn
Resistant ascites in alcoholic liver cirrhosis: course and prognosis.
October 1978, The American journal of digestive diseases,
J J Alberti-Flor, and G D Dunn
[Reinfusion treatment of therapy-resistant ascites. Preliminary experiences with a new method (author's transl)].
May 1974, Deutsche medizinische Wochenschrift (1946),
J J Alberti-Flor, and G D Dunn
[Therapy of refractory ascites: concentration and reinfusion].
May 1987, Minerva medica,
J J Alberti-Flor, and G D Dunn
[The reinfusion of ascitic fluid into patients with liver cirrhosis and ascites resistant to drug treatment].
January 1989, Vutreshni bolesti,
J J Alberti-Flor, and G D Dunn
[Cell-free and concentrated ascites reinfusion therapy(CART)].
December 2012, Gan to kagaku ryoho. Cancer & chemotherapy,
J J Alberti-Flor, and G D Dunn
Management of Refractory Ascites for Liver Transplant Candidates: A Novel Cell-free and Concentrated Ascites Reinfusion Therapy.
October 2019, Transplantation proceedings,
J J Alberti-Flor, and G D Dunn
9- -fluorohydrocortisone induced ascites in alcoholic liver disease.
October 1971, Gastroenterology,
J J Alberti-Flor, and G D Dunn
CART: Cell-free and Concentrated Ascites Reinfusion Therapy against malignancy-related ascites.
October 2017, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis,
J J Alberti-Flor, and G D Dunn
[Reinfusion ascites therapy: considerations after a year's experience].
January 1994, Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques,
Copied contents to your clipboard!